12
|
55
|
4jyuL |
Structure of factor viia in complex with the inhibitor (2r)-2-[(1-aminoisoquinolin-6-yl)amino]-2-[3-ethoxy-4-(propan-2-yloxy)phenyl]-n-(phenylsulfonyl)ethanamide |
12
|
55
|
4jzfL |
Structure of factor viia in complex with the inhibitor 2-{2-[(3-carbamoylphenyl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2s)-1-hydroxy-3,3-dimethylbutan-2-yl]carbamoyl}benzoic acid |
14
|
55
|
4jyvL |
Structure of factor viia in complex with the inhibitor (2r)-2-[3-ethoxy-4-(propan-2-yloxy)phenyl]-2-(isoquinolin-6-ylamino)-n-[(3-sulfamoylphenyl)sulfonyl]ethanamide |
30
|
205
|
4gu4A |
Crystal structure of the t1l reovirus attachment protein sigma1 in complex with alpha-2,3-sialyllactose |
30
|
205
|
4gu3A |
Crystal structure of the t1l reovirus attachment protein sigma1 in complex with the gm2 glycan |
175
|
692
|
4g1mB |
Re-refinement of alpha v beta 3 structure |
211
|
1012
|
3r05A |
Structure of neurexin 1 alpha (domains lns1-lns6), with splice insert ss3 |
203
|
552
|
4fm5A |
X-ray structure of des-methylflurbiprofen bound to murine cox-2 |
206
|
1003
|
3qcwA |
Structure of neurexin 1 alpha (domains lns1-lns6), no splice inserts |
206
|
552
|
3qh0A |
X-ray crystal structure of palmitic acid bound to the cyclooxygenase channel of cyclooxygenase-2 |
188
|
552
|
3q7dA |
Structure of (r)-naproxen bound to mcox-2. |
196
|
551
|
3qmoA |
X-ray crystal structure of ns-398 bound to the cyclooxygenase channel of cyclooxygenase-2 |
12
|
52
|
3q3kB |
Factor xa in complex with a phenylenediamine derivative |
212
|
1014
|
3poyA |
Crystal structure of the alpha-neurexin-1 ectodomain, lns 2-6 |
176
|
552
|
3pghA |
Cyclooxygenase-2 (prostaglandin synthase-2) complexed with a non-selective inhibitor, flurbiprofen |
202
|
551
|
3oltA |
X-ray crystal structure of arachidonic acid bound to the cyclooxygenase channel of r513h murine cox-2 |
62
|
400
|
3p5bL |
The structure of the ldlr/pcsk9 complex reveals the receptor in an extended conformation |
200
|
551
|
3oluA |
X-ray crystal structure of 1-arachidonoyl glycerol bound to the cyclooxygenase channel of r513h murine cox-2 |
200
|
552
|
3ntgA |
Crystal structure of cox-2 with selective compound 23d-(r) |
199
|
552
|
3ntbA |
Structure of 6-methylthio naproxen analog bound to mcox-2. |
205
|
552
|
3nt1A |
High resolution structure of naproxen:cox-2 complex. |
7
|
47
|
3njpC |
The extracellular and transmembrane domain interfaces in epidermal growth factor receptor signaling |
179
|
553
|
3n8yB |
Structure of aspirin acetylated cyclooxygenase-1 in complex with diclofenac |
178
|
553
|
3n8zA |
Crystal structure of cyclooxygenase-1 in complex with flurbiprofen |
176
|
553
|
3n8yA |
Structure of aspirin acetylated cyclooxygenase-1 in complex with diclofenac |
187
|
553
|
3n8wA |
Crystal structure of r120q/native cyclooxygenase-1 heterodimer mutant in complex with flurbiprofen |
184
|
553
|
3n8wB |
Crystal structure of r120q/native cyclooxygenase-1 heterodimer mutant in complex with flurbiprofen |
162
|
553
|
3n8vA |
Crystal structure of unoccupied cyclooxygenase-1 |
180
|
553
|
3n8xA |
Crystal structure of cyclooxygenase-1 in complex with nimesulide |
192
|
552
|
3mqeA |
Structure of sc-75416 bound at the cox-2 active site |
204
|
552
|
3mdlA |
X-ray crystal structure of 1-arachidonoyl glycerol bound to the cyclooxygenase channel of cyclooxygenase-2 |
13
|
52
|
3m37L |
Factor xa in complex with the inhibitor 1-[2-(aminomethyl)phenyl]-n-(3-fluoro-2'-sulfamoylbiphenyl-4-yl)-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide (dpc602) |
12
|
52
|
3m36L |
Factor xa in complex with the inhibitor 1-[3-(aminomethyl)phenyl]-n-[3-fluoro-2'-(methylsulfonyl)biphenyl-4-yl]-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide (dpc423) |
202
|
552
|
3ln0A |
Structure of compound 5c-s bound at the active site of cox-2 |
10
|
57
|
3lc3B |
Benzothiophene inhibitors of factor ixa |
6
|
57
|
3ltfB |
Crystal structure of the drosophila epidermal growth factor receptor ectodomain in complex with spitz |
12
|
51
|
3liwB |
Factor xa in complex with (r)-2-(1-adamantylcarbamoylamino)-3-(3-carbamidoyl-phenyl)-n-phenethyl-propionic acid amide |
8
|
51
|
3ltgD |
Crystal structure of the drosophila epidermal growth factor receptor ectodomain complexed with a low affinity spitz mutant |
202
|
552
|
3ln1A |
Structure of celecoxib bound at the cox-2 active site |
10
|
54
|
3lc5B |
Selective benzothiophine inhibitors of factor ixa |
22
|
124
|
3laqA |
Structure-based engineering of species selectivity in the upa-upar interaction |
202
|
551
|
3krkA |
X-ray crystal structure of arachidonic acid bound in the cyclooxygenase channel of l531f murine cox-2 |
13
|
52
|
3kqeL |
Factor xa in complex with the inhibitor 3-methyl-1-(3-(5- oxo-4,5-dihydro-1h-1,2,4-triazol-3-yl)phenyl)-6-(2'- (pyrrolidin-1-ylmethyl)biphenyl-4-yl)-5,6-dihydro-1h- pyrazolo[3,4-c]pyridin-7(4h)-one |
12
|
50
|
3kl6B |
Discovery of tetrahydropyrimidin-2(1h)-one derivative tak-442: a potent, selective and orally active factor xa inhibitor |
12
|
52
|
3kqcL |
Factor xa in complex with the inhibitor 6-(2'- (methylsulfonyl)biphenyl-4-yl)-1-(3-(5-oxo-4,5-dihydro-1h- 1,2,4-triazol-3-yl)phenyl)-3-(trifluoromethyl)-5,6- dihydro-1h-pyrazolo[3,4-c]pyridin-7(4h)-one |
13
|
54
|
3kcgL |
Crystal structure of the antithrombin-factor ixa-pentasaccharide complex |
137
|
553
|
3kk6A |
Crystal structure of cyclooxygenase-1 in complex with celecoxib |
18
|
89
|
3k9xA |
X-ray crystal structure of human fxa in complex with (s)-n-((2-methylbenzofuran-5-ylamino)(2-oxo-1-(2-oxo-2- (pyrrolidin-1-yl)ethyl)azepan-3- ylamino)methylene)nicotinamide |
12
|
52
|
3kqbL |
Factor xa in complex with the inhibitor n-(3-fluoro-2'- (methylsulfonyl)biphenyl-4-yl)-1-(3-(5-oxo-4,5-dihydro-1h- 1,2,4-triazol-3-yl)phenyl)-3-(trifluoromethyl)-1h- pyrazole-5-carboxamide |
10
|
52
|
3kqdL |
Factor xa in complex with the inhibitor 1-(3-(5-oxo-4,5- dihydro-1h-1,2,4-triazol-3-yl)phenyl)-6-(2'-(pyrrolidin-1- ylmethyl)biphenyl-4-yl)-3-(trifluoromethyl)-5,6-dihydro- 1h-pyrazolo[3,4-c]pyridin-7(4h)-one |